BCRX icon

BioCryst Pharmaceuticals

124 hedge funds and large institutions have $740M invested in BioCryst Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 43 increasing their positions, 41 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
124
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$16.4M
Puts
$6.5M
Net Calls
Net Calls Change

Top Sellers

1 -$21.6M
2 -$16.1M
3 -$11M
4
Citadel Advisors
Citadel Advisors
Florida
-$7.42M
5
VM
VHCP Management
New York
-$5.58M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$161M
2
$88.4M
3
$85.5M
4
$35.9M
5
$33.2M
6
$29M
7
$28.2M
8
$25.4M
9
$19.3M
10
$16.1M
11
$15.5M
12
$15.1M
13
$13.7M
14
$13.6M
15
$12.6M
16
$12.3M
17
$11.7M
18
$10.9M
19
$10.3M
20
$7.39M
21
$5.59M
22
$4.98M
23
$4.77M
24
$3.85M
25
$3.77M